Women with triple negative breast cancer will gain access to pembrolizumab after deal with its manufacturer
Action Cancer ambassador shares her journey after routine screening diagnosis
New NHS drug offers lifeline to 1,600 women with rare aggressive breast cancer
The rise of the 'long-waiter' – why cancer waiting times are showing the pressure more than ever before - Cancer Research UK - Cancer News
Cancers, Free Full-Text
d1ijoxngr27nfi.cloudfront.net/images/default-sourc
New NHS drug offers lifeline to 1,600 women with rare aggressive breast cancer
NICE says new triple negative advanced breast cancer drug too expensive for NHS use, News, News
Breast cancer wonder drug approved by NHS, UK, News
Anastrozole: Thousands to be offered drug to prevent breast cancer in England - BBC News